STE vs HSIC

For growth investors, STERIS plc (STE) is the stronger pick with 6.

2% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate STERIS plc (STE) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 6x versus STERIS plc at 34. 5x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: STERIS plc wins at 3. 86x versus Henry Schein, Inc. 's 4. 21x.

Over the past 5 years, STERIS plc (STE) delivered a total return of +5.

9%, compared to -12. 5% for Henry Schein, Inc. (HSIC). Over 10 years, the gap is even starker: STE returned +220. 0% versus HSIC's +5. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), STERIS plc (STE) is the lower-risk stock at 0.

69β versus Henry Schein, Inc. 's 0. 73β — meaning HSIC is approximately 6% more volatile than STE relative to the S&P 500. On balance sheet safety, STERIS plc (STE) carries a lower debt/equity ratio of 33% versus 77% for Henry Schein, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), STERIS plc (STE) is pulling ahead at 6.

2% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: STERIS plc grew EPS 62. 7% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, STE leads at 8. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

STERIS plc (STE) is the more profitable company, earning 11.

3% net margin versus 3. 0% for Henry Schein, Inc. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STE leads at 15. 9% versus 5. 7% for HSIC. At the gross margin level — before operating expenses — STE leads at 44. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, STERIS plc (STE) is the more undervalued stock at a PEG of 3. 86x versus Henry Schein, Inc. 's 4. 21x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 3x forward P/E versus 21. 0x for STERIS plc — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HSIC: 22. 6% to $86. 43.

In this comparison, STE (1.

0% yield) pays a dividend. HSIC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, STERIS plc (STE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

69), 1. 0% yield, +220. 0% 10Y return). Both have compounded well over 10 years (STE: +220. 0%, HSIC: +5. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

STE pays a dividend while HSIC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.